Key Financial’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
Key Financial's SRPT Position: Q3 2026 in Review
Key Financial reduced its Sarepta Therapeutics (SRPT) stake by 95% in Q3 2026, selling an estimated $18.7K and leaving 50 shares worth $902. The position accounts for ﹤0.01% of the portfolio, ranked #1185.
Key Financial first reported a position in SRPT in Q1 2020 and has held it in 25 quarters since. The position peaked at $18.9K in Q2 2026. 228 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.
- Key Financial held 50 shares of Sarepta Therapeutics worth $902 as of Q3 2026.
- Key Financial sold 1,000 Sarepta Therapeutics shares in Q3 2026, an estimated $18.7K.
- Sarepta Therapeutics made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1185 holding.
- Key Financial first reported a position in Sarepta Therapeutics in Q1 2020 and has held it in 25 quarters since.
- Key Financial's Sarepta Therapeutics position peaked at $18.9K in Q2 2026.
- 228 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.